Summary:
The study will compare the effects of an investigational drug to a placebo in subjects with chronic cough lasting over 8 weeks. The study drug (lozenges), is intended to decrease coughing activity.
Study will last up to 6 weeks and includes 5 site visits. Participation in this study may help doctors find ways to treat others with Chronic Refractory Cough in the future.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have had chronic cough for more than 8 weeks
•
Have been treated for asthma, post nasal drip, or GERD
•
Have also had cough without a diagnosis
Qualified Participants May Receive:
Investigational medication, study related procedures at no cost, and $150 for Completion of Study.